UK markets closed

Bionik Laboratories Corp. (BNKL)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 10:33AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.25M
Enterprise value 3.23M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.38
Price/book (mrq)N/A
Enterprise value/revenue 1.79
Enterprise value/EBITDA -0.68

Trading information

Stock price history

Beta (5Y monthly) -1.32
52-week change 3-79.92%
S&P500 52-week change 322.38%
52-week high 31.4500
52-week low 30.0000
50-day moving average 30.1000
200-day moving average 30.1588

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 512.48M
Implied shares outstanding 612.48M
Float 83.71M
% held by insiders 180.00%
% held by institutions 10.80%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 330 Oct 2018
Ex-dividend date 4N/A
Last split factor 21:150
Last split date 330 Oct 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin -273.99%
Operating margin (ttm)-248.47%

Management effectiveness

Return on assets (ttm)-74.23%
Return on equity (ttm)-768.84%

Income statement

Revenue (ttm)1.81M
Revenue per share (ttm)0.26
Quarterly revenue growth (yoy)162.00%
Gross profit (ttm)N/A
EBITDA -4.71M
Net income avi to common (ttm)-4.95M
Diluted EPS (ttm)-0.7200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)427.38k
Total cash per share (mrq)0.03
Total debt (mrq)2.41M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.20
Book value per share (mrq)-0.23

Cash flow statement

Operating cash flow (ttm)-3.39M
Levered free cash flow (ttm)-1.58M